FDA.reportPublic FDA data

24 HR Oxtellar 300 MG Extended Release Oral Tablet

RxCUI
1365847
RxNorm name
24 HR Oxtellar 300 MG Extended Release Oral Tablet
Display name
24 HR Oxtellar 300 MG Extended Release Oral Tablet
Full name
24 HR Oxtellar 300 MG Extended Release Oral Tablet
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:39:14

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
aa610e56-1d1d-11e1-8bc2-0800200c9a66Oxtellar XR 300 MG 24HR Extended Release Oral Tablet, Once-Daily [PSN] · 24 HR oxcarbazepine 300 MG Extended Release Oral Tablet [Oxtellar] [SBD] · 24 HR Oxtellar 300 MG Extended Release Oral Tablet [SY] · Oxtellar XR 300 MG 24 HR Extended Release Oral Tablet [SY]421These highlights do not include all the information needed to use OXTELLAR XR ® safely and effectively. See full prescribing information for OXTELLAR XR ® . OXTELLAR XR ® (oxcarbazepine) extended-release tablets, for oral use Initial U.S. Approval: 200020251022